ArticleMolecular cancer therapeutics2012

Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis.

Giulio Francia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.